Open AccessStem cell and EMT features of HNSCC-lines are reversed by the aldehyde hydrogenase inhibitor Disulfiram (Antabuse®)
Author(s) -
Wenhao Yao,
Xu Qian,
O Sebastian,
Konrad Klinghammer,
Andreas M. Kaufmann,
Andreas E. Albers
Publication year - 2019
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0039-1686897
Subject(s) - disulfiram , aldehyde dehydrogenase , cancer research , cancer stem cell , drug resistance , cancer , medicine , cell culture , head and neck squamous cell carcinoma , cell , oncology , pharmacology , head and neck cancer , biology , gene , biochemistry , microbiology and biotechnology , genetics